Cargando…

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma

BACKGROUND: Ezrin is a cytoskeletal protein that is involved in tumor growth and invasion. It has been suggested that Ezrin expression plays an important role in tumor metastasis. This study is aimed to investigate the clinicopathological significance of Ezrin overexpression in gastric adenocarcinom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Jingchun, Jin, Tiefeng, Quan, Meiling, Piao, Yingshi, Lin, Zhenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502371/ https://www.ncbi.nlm.nih.gov/pubmed/23039327 http://dx.doi.org/10.1186/1746-1596-7-135

Ejemplares similares

Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer
por: Jin, Tiefeng, et al.
Publicado: (2014)

High expression of DEK predicts poor prognosis of gastric adenocarcinoma
por: Piao, Junjie, et al.
Publicado: (2014)

High expression of ezrin predicts poor prognosis in uterine cervical cancer
por: Kong, Jienan, et al.
Publicado: (2013)

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
por: Li, Zhenling, et al.
Publicado: (2015)

Ezrin promotes pancreatic cancer cell proliferation and invasion through activating the Akt/mTOR pathway and inducing YAP translocation
por: Quan, Chunji, et al.
Publicado: (2019)

Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer
por: Li, M., et al.
Publicado: (2017)

NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix
por: Ma, Yue, et al.
Publicado: (2014)

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
por: Lin, Lijuan, et al.
Publicado: (2013)

Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC
por: Piao, Junjie, et al.
Publicado: (2016)

PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer
por: Chen, Liyan, et al.
Publicado: (2017)

Ezrin promotes breast cancer progression by modulating AKT signals
por: Li, Nan, et al.
Publicado: (2019)

Trop2 is overexpressed in gastric cancer and predicts poor prognosis
por: Zhao, Wei, et al.
Publicado: (2015)

Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer
por: Lin, Lijuan, et al.
Publicado: (2014)

Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis
por: Huang, Chao, et al.
Publicado: (2020)

Overexpressing PLOD family genes predict poor prognosis in gastric cancer
por: Li, Shan-Shan, et al.
Publicado: (2020)

Ezrin Immunoexpression in Prostate Adenocarcinomas
por: POPESCU, TUDOR CRISTIAN TIMOTEI, et al.
Publicado: (2022)

Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma
por: Wang, Jue, et al.
Publicado: (2016)

Overexpression of TC2N is associated with poor prognosis in gastric cancer
por: Xu, Jianbo, et al.
Publicado: (2021)

Overexpression of PSMA7 predicts poor prognosis in patients with gastric cancer
por: Xia, Shujing, et al.
Publicado: (2019)

Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma
por: Ji, Meiying, et al.
Publicado: (2017)

miR-20b overexpression is predictive of poor prognosis in gastric cancer
por: Xue, Tong-min, et al.
Publicado: (2015)

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma
por: Wei, Dong, et al.
Publicado: (2023)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

PRDX4 overexpression is associated with poor prognosis in gastric cancer
por: Park, Sun Yi, et al.
Publicado: (2020)

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
por: Wang, Dandan, et al.
Publicado: (2014)

Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition
por: Kong, Jienan, et al.
Publicado: (2016)

CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration
por: Zhang, Ronghua, et al.
Publicado: (2020)

Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer
por: DUAN, JIANGMAN, et al.
Publicado: (2016)

GPR116 overexpression correlates with poor prognosis in gastric cancer
por: Zheng, Tian, et al.
Publicado: (2021)

GEMIN6 Overexpression Correlates with the Low Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma
por: Peng, Yunsong, et al.
Publicado: (2022)

Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma
por: Ding, Fang, et al.
Publicado: (2018)

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Overexpression of Musashi-1 protein is associated with progression and poor prognosis of gastric cancer
por: Shou, Zhangxuan, et al.
Publicado: (2017)

Overexpression of TC2N is associated with poor prognosis in gastric cancer: Erratum
por: Xu, Jianbo, et al.
Publicado: (2022)

Ubiquitin‐specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosis
por: Fang, Chia‐Lang, et al.
Publicado: (2018)

CREM Is Correlated With Immune-Suppressive Microenvironment and Predicts Poor Prognosis in Gastric Adenocarcinoma
por: Yu, Kuai, et al.
Publicado: (2021)

G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo
por: Zhu, Kun, et al.
Publicado: (2022)

Overexpression of RACK1 Predicts Poor Prognosis in Melanoma
por: Shen, Congcong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u6hbkbu2ta526jvlg0h09ks843